Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析

◆英語タイトル:Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1099
◆発行会社(調査会社):GlobalData
◆発行日:2020年2月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Anavex Life Sciences Corp (AVXL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and other central nervous system (CNS) diseases, pain and various types of cancer. The company’s target indications include Alzheimer’s disease, Parkinson’s disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study. Anavex’s lead compound ANAVEX 2-73 is being developed for the treatment of Alzheimer’s disease, Parkinson’s disease and potentially other CNS diseases, including rare diseases. Anavex is headquartered in New York, the US.

Anavex Life Sciences Corp Key Recent Developments

Feb 06,2020: Anavex Life Sciences reports fiscal 2020 first quarter financial results and provides clinical study updates
Feb 04,2020: Anavex Life Sciences to present and participate in a panel at the 2020 BIO CEO & Investor Conference
Dec 16,2019: Anavex Life Sciences reports fiscal year 2019 financial results and provides clinical study updates
Aug 07,2019: Anavex Life Sciences reports fiscal 2019 third quarter financial results and provides clinical study updates
May 08,2019: Anavex Life Sciences reports fiscal 2019 second quarter financial results and provides clinical study updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Anavex Life Sciences Corp – Key Facts
Anavex Life Sciences Corp – Key Employees
Anavex Life Sciences Corp – Key Employee Biographies
Anavex Life Sciences Corp – Major Products and Services
Anavex Life Sciences Corp – History
Anavex Life Sciences Corp – Company Statement
Anavex Life Sciences Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Anavex Life Sciences Corp – Business Description
R&D Overview
Anavex Life Sciences Corp – Corporate Strategy
Anavex Life Sciences Corp – SWOT Analysis
SWOT Analysis – Overview
Anavex Life Sciences Corp – Strengths
Anavex Life Sciences Corp – Weaknesses
Anavex Life Sciences Corp – Opportunities
Anavex Life Sciences Corp – Threats
Anavex Life Sciences Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Anavex Life Sciences Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 06, 2020: Anavex Life Sciences reports fiscal 2020 first quarter financial results and provides clinical study updates
Feb 04, 2020: Anavex Life Sciences to present and participate in a panel at the 2020 BIO CEO & Investor Conference
Dec 16, 2019: Anavex Life Sciences reports fiscal year 2019 financial results and provides clinical study updates
Aug 07, 2019: Anavex Life Sciences reports fiscal 2019 third quarter financial results and provides clinical study updates
May 08, 2019: Anavex Life Sciences reports fiscal 2019 second quarter financial results and provides clinical study updates
Feb 07, 2019: Anavex Life Sciences reports fiscal 2019 first quarter financial results and provides clinical study updates
Jan 02, 2019: Anavex Life Sciences names Walter E Kaufmann, MD as chief medical officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Anavex Life Sciences Corp, Key Facts
Anavex Life Sciences Corp, Key Employees
Anavex Life Sciences Corp, Key Employee Biographies
Anavex Life Sciences Corp, Major Products and Services
Anavex Life Sciences Corp, History
Anavex Life Sciences Corp, Subsidiaries
Anavex Life Sciences Corp, Key Competitors
Anavex Life Sciences Corp, Ratios based on current share price
Anavex Life Sciences Corp, Annual Ratios
Anavex Life Sciences Corp, Interim Ratios
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Anavex Life Sciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Anavex Life Sciences Corp, Performance Chart (2015 - 2019)
Anavex Life Sciences Corp, Ratio Charts
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shinsegae Inc (004170):企業の財務・戦略的SWOT分析
    Shinsegae Inc (004170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Oil States International, Inc.:企業の戦略・SWOT・財務分析
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Godrej Consumer Products Limited:企業のM&A・事業提携・投資動向
    Godrej Consumer Products Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Godrej Consumer Products Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Albumedix AS-製薬・医療分野:企業M&A・提携分析
    Summary Albumedix A/S (Albumedix), a subsidiary of Novozymes A/S, is a developer of albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Its product Recombumin is a recombinant human albumin used in the manufacture of …
  • Olmsted Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes education, neurology, psychia …
  • First Hawaiian Inc:企業の戦略・SWOT・財務情報
    First Hawaiian Inc - Strategy, SWOT and Corporate Finance Report Summary First Hawaiian Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Broadcom Inc (AVGO):企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • IndusInd Bank Ltd:企業の戦略・SWOT・財務情報
    IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sherritt International Corp (S):石油・ガス:M&Aディール及び事業提携情報
    Summary Sherritt International Corp (Sherritt) is a natural resources company. It carries out mining and refining activities for the production of nickel and cobalt from lateritic ores with ownership stake in Moa Joint Venture and Ambatovy Joint Venture. The company also explores, develops and produ …
  • Altius Minerals Corporation:企業のM&A・事業提携・投資動向
    Altius Minerals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altius Minerals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Concho Resources Inc.:戦略・SWOT・企業財務分析
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cathay Financial Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Cathay Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cathay Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Tethys Oil AB (TETY):石油・ガス:M&Aディール及び事業提携情報
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • Geron Corp (GERN):医療機器:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • BRF SA:戦略・SWOT・企業財務分析
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Celltrion Inc (068270):企業の財務・戦略的SWOT分析
    Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sandoz International GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • RWE AG (RWE)-石油・ガス分野:企業M&A・提携分析
    Summary RWE AG (RWE) is an energy company that generates, transmits and distributes electricity. The company generates electricity using various sources such as gas, hard coal, lignite, nuclear, hydro, biomass and renewables. It also produces oil, gas and lignite; and distributes and supplies gas. T …
  • HoMedics LLC:企業の戦略的SWOT分析
    HoMedics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆